SG Capital Management’s DexCom DXCM Stock Holding History

SG Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-304,536	Closed	-$26.6M	–	74
2025 Q2	$26.6M	Buy	+304,536	New	+$23.9M	1.84%	15

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Capital Management's DXCM Position: Q3 2025 in Review

SG Capital Management sold out of DexCom (DXCM) in Q3 2025, closing a stake of 304,536 shares — an estimated $26.6M sold.

SG Capital Management first reported a position in DXCM in Q2 2025 and held it in 1 quarter. The position peaked at $26.6M in Q2 2025. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

SG Capital Management reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
SG Capital Management sold 304,536 DexCom shares in Q3 2025, an estimated $26.6M.
SG Capital Management first reported a position in DexCom in Q2 2025 and held it in 1 quarter.
SG Capital Management's DexCom position peaked at $26.6M in Q2 2025.
910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on SG Capital Management's 13F filing for Q3 2025, filed 7 Nov 2025.